Molbio Diagnostics IPO GMP Today
ListedUpdated 17 August 2026, 5:30 PM IST· Mainboard· Listing 17 Aug 2026
Molbio Diagnostics IPO opens on 10 August 2026. Molbio Diagnostics IPO GMP is Rs 120.00 today. Listing price estimate is Rs 927.00 (issue price Rs 807.00). Listing gain estimate: 14.87%.
Molbio Diagnostics IPO GMP Day Wise
Daily grey market premium, estimated listing price, and profit per lot
GMP for Molbio Diagnostics IPO started at Rs 0 on 4 August 2026 and stood at Rs 116 on 17 August 2026. The sharpest single-day jump was from Rs 0 on 4 Aug 2026 to Rs 170 on 5 Aug 2026. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Est. Profit |
|---|---|---|---|---|
| 17 Aug 2026Today | Rs 807.00 | Rs 116.00 | Rs 923.00 (+14.37%) | Rs 2,088.00 |
| 16 Aug 2026 | Rs 807.00 | Rs 120.00 | Rs 927.00 (+14.87%) | Rs 2,160.00 |
| 15 Aug 2026 | Rs 807.00 | Rs 125.00 | Rs 932.00 (+15.49%) | Rs 2,250.00 |
| 14 Aug 2026 | Rs 807.00 | Rs 115.00 | Rs 922.00 (+14.25%) | Rs 2,070.00 |
| 13 Aug 2026 | Rs 807.00 | Rs 156.00 | Rs 963.00 (+19.33%) | Rs 2,808.00 |
| 12 Aug 2026 | Rs 807.00 | Rs 154.00 | Rs 961.00 (+19.08%) | Rs 2,772.00 |
| 11 Aug 2026 | Rs 807.00 | Rs 138.00 | Rs 945.00 (+17.10%) | Rs 2,484.00 |
| 10 Aug 2026 | Rs 807.00 | Rs 127.00 | Rs 934.00 (+15.74%) | Rs 2,286.00 |
| 9 Aug 2026 | Rs 807.00 | Rs 132.00 | Rs 939.00 (+16.36%) | Rs 2,376.00 |
| 8 Aug 2026 | Rs 807.00 | Rs 130.00 | Rs 937.00 (+16.11%) | Rs 2,340.00 |
| 7 Aug 2026 | Rs 807.00 | Rs 180.00 | Rs 987.00 (+22.30%) | Rs 3,240.00 |
| 6 Aug 2026 | Rs 807.00 | Rs 220.00 | Rs 1,027.00 (+27.26%) | Rs 3,960.00 |
| 5 Aug 2026 | Rs 807.00 | Rs 170.00 | Rs 977.00 (+21.07%) | Rs 3,060.00 |
| 4 Aug 2026 | Rs 807.00 | Rs 0.00 | Rs 807.00 (+0.00%) | Rs 0.00 |
Molbio Diagnostics IPO Listing Price
Estimated from today’s GMP
Based on today's GMP, Molbio Diagnostics IPO listing price estimate is Rs 927.00 per share (issue price Rs 807.00 + GMP Rs 120.00).
Actual listing price will be known on 17 August 2026 when the stock lists on NSE/BSE.
Molbio Diagnostics IPO Listing Gain
Estimated profit per lot from grey market premium
Lot size: 18 shares
GMP today: Rs 120.00
Estimated listing gain per lot: Rs 120.00 × 18 = Rs 2,160.00
At about 14.9% GMP, demand looks positive but not aggressive. Listing outcome will depend heavily on subscription data and market mood on listing day.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
Molbio Diagnostics IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Molbio Diagnostics IPO is 70.26x. Compare this with the GMP trend to see if demand aligns. The GMP move around 5 Aug 2026 may reflect how the market reacted once the subscription window activity picked up after 10 Aug 2026.
See live figures on the Molbio Diagnostics IPO Subscription Status page.
Molbio Diagnostics IPO Details
| Field | Value |
|---|---|
| Price Band | ₹768.0 - ₹807.0 |
| Issue Size | ₹939.70 Cr |
| Lot Size | 18 shares |
| IPO Type | Mainboard |
| Open Date | 10 Aug 2026 |
| Close Date | 12 Aug 2026 |
| Listing Date | 17 Aug 2026 |
| Subscription | 70.26x |
Molbio Diagnostics IPO full details (financials, peers, review).
About Molbio Diagnostics IPO
Molbio Diagnostics Limited (incorporated in 2000 as Molbio Diagnostics Private Limited) is a point-of-care (POC) diagnostics company focused on delivering accurate, rapid, and cost-effective healthcare technologies for infectious and non-communicable diseases. The company developed the 'Truenat' platform, a portable polymerase chain reaction (PCR) system that enables decentralized molecular testing for 30 diseases across 42 assays, patented in over 100 countries. Its Truenat TB test is WHO-endorsed for initial TB diagnosis and rifampicin resistance detection. The company operates five manufacturing facilities in Goa, Visakhapatnam, and Bengaluru, supplying products directly and via distributors to public health programs, laboratories, and hospitals across 80+ countries.
Molbio Diagnostics IPO GMP FAQs
What is Molbio Diagnostics IPO GMP today?
Molbio Diagnostics IPO GMP is ₹120 as of 19 August 2026, 4:47 AM IST. At issue price ₹807, that is +14.87% expected listing gain in the grey market.
What is Molbio Diagnostics IPO grey market premium (GMP)?
The grey market premium (GMP) for Molbio Diagnostics IPO is ₹120 today. GMP is the unofficial premium traders pay above the issue price of ₹807 before listing on NSE/BSE.
What is Molbio Diagnostics IPO expected returns?
Molbio Diagnostics IPO expected returns based on today's GMP are +14.87% over the issue price of ₹807. Estimated listing price is ₹927 per share. Actual listing gain on 17 August 2026 may differ.
What is the estimated listing price of Molbio Diagnostics IPO?
Based on today's GMP, Molbio Diagnostics IPO estimated listing price is ₹927 per share (issue price ₹807 + GMP ₹120). The actual listing price will be set on 17 August 2026 when trading starts.
What is the expected profit per lot in Molbio Diagnostics IPO?
At GMP of ₹120 and lot size of 18 shares, estimated grey market profit is ₹2,160 (1 lot × 18 shares × ₹120). This is unofficial and not guaranteed on listing day.
Will Molbio Diagnostics IPO list at GMP price?
Molbio Diagnostics IPO may list around ₹927 based on current GMP of ₹120, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 17 August 2026, the opening price depends on market sentiment, final subscription, and index levels.
What is Molbio Diagnostics IPO issue price and lot size?
Molbio Diagnostics IPO issue price is ₹807 per share (price band ₹768.0 - ₹807.0). Lot size is 18 shares. Minimum application is 1 lot.
When is Molbio Diagnostics IPO listing date?
Molbio Diagnostics IPO is expected to list on 17 August 2026 on NSE and BSE. GMP can still move until listing day.
What is Molbio Diagnostics IPO GMP high and low?
Molbio Diagnostics IPO GMP made a high of ₹220 on 6 Aug 2026 and a low of ₹0 on 4 Aug 2026 in tracked grey market data.
Can Molbio Diagnostics IPO GMP change after subscription closes?
Yes. Molbio Diagnostics IPO closed on 12 August 2026. GMP often moves until listing (17 August 2026) based on allotment buzz, market mood, and news. Keep this page handy for the latest figure.
What is Molbio Diagnostics IPO subscription status?
Live category-wise subscription for Molbio Diagnostics IPO is on the Molbio Diagnostics IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check Molbio Diagnostics IPO allotment status?
You can check Molbio Diagnostics IPO allotment with your PAN on the Molbio Diagnostics IPO Allotment Status page, the registrar site, BSE, or the IPOwiz App.
Sources
We match Molbio Diagnostics IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews GMP figures before they go live.